European Radiology 34(2): 13141323
Therefore, given the lack of comprehensive understanding of the risks to breastfeeding infants, medical practitioners and health care providers generally recommend against the use of Ozempic during breastfeeding, except in cases where the medicinal benefits greatly surpass the potential risks
What the body does with that same signal changes a great deal
For the comparison of the semaglutide OW cohort versus the SGLT2i cohort, 439 and 1089 patients, were identified respectively
Those adverse events in aggregate included: nausea and vomiting, gastroesophageal reflux disease (GERD), sleep disturbances, bone pain, abdominal pain, hypotension, headaches, nephrolithiasis, and anemia